November 5th 2024
There has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Shaping the Management of COPD with Biologic Therapy
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Charting the Path to Precision Diagnosis: Detection and Treatment Approaches for Oncogenic Mutations in NSCLC
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
What Do Stakeholders Think About the GAP for Influenza Vaccines' First 10 Years?
December 5th 2016Ten years ago in Geneva, the World Health Organization (WHO) unveiled what is now called the Global Action Plan for Influenza Vaccines (GAP), a comprehensive approach to meeting the demand for vaccines should there be a pandemic anywhere in the world. How is it doing?
Read More
Researchers Study Link Between Pneumonia Risk and Antidementia Drugs
December 4th 2016Pneumonia is the fourth leading cause of hospitalization among those living with Alzheimer’s disease, and now a new study by University of Eastern Finland researchers examined the link between the infection and certain antidementia drugs.
Read More
Pandemic Influenza Top of Mind for CDC Director
November 30th 2016Thomas Frieden, MD, MPH, director of the CDC, and Susan Desmond-Hellmann, MD, chief executive of the Bill and Melinda Gates Foundation discuss how governments and business organizations should prepare for pandemics, especially a potential influenza pandemic.
Read More
Poultry Culled and Quarantines Up as Bird Flu Outbreak Hits South Korea
November 28th 2016A recent outbreak of highly pathogenic avian influenza in commercial chickens and ducks in South Korea has health officials in the country on high alert and some poultry farmers taking quarantine measures.
Read More
Cystic Fibrosis Patients Can Transmit Antibiotic-resistant Infections to Each Other
November 17th 2016In a new study, researchers from the United Kingdom have found that cystic fibrosis patients are more likely to pick up multi-drug resistant infections in hospitals than was previously believed.
Read More
Multidrug-resistant Tuberculosis More Widespread in Western Africa Than Previously Thought
November 13th 2016The scope of multidrug-resistant tuberculosis in West Africa, until recently, has not been well-understood, but a new study on eight countries in the region shows that the superbug is more common than previous estimates suggested.
Read More
How Clinical and Environmental Factors Impact Legionella Growth
November 12th 2016Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains why Legionella is such a challenging pathogen.
Watch
Why is Legionnaires' on the Rise in the US?
November 10th 2016Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains the current Legionella situation.
Watch
Study Finds that Nearly One in Four Are Infected with Latent Tuberculosis
November 9th 2016A new study from United Kingdom researchers finds that nearly one-quarter of the global population is infected with latent tuberculosis (TB), a finding that exposes the challenges ahead for the World Health Organization’s End TB Strategy.
Read More
Influenza Antiviral Treatments: Prescribing Practices Across the US
November 8th 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, explains her recent research on influenza antiviral treatment prescribing practices in 60 outpatient settings across the United States.
Watch
WHO Report Says We're Off Target on TB Epidemic
November 7th 2016The World Health Organization (WHO) has released their Global Tuberculosis Report for 2016, emphasizing that today’s global actions and investments are falling far short of what is needed to stop the worldwide tuberculosis (TB) epidemic.
Read More
Measuring the Impact of Comorbidities on 30-day Mortality in Older Adults with Pneumonia
November 4th 2016Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, Wesley Healthcare, discusses his research on 30-day mortality in adults with pneumococcal disease.
Watch